Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin

Expert Opinion on Drug Delivery

Volumn 6, Issue 2, 2009, Pages 149-163

  El Maghraby, G M ^a,b   Williams, A C ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b TANTA UNIVERSITY   (Egypt)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

Ethosomes; Liposomes; Macromolecular drugs; Niosomes; Transdermal drug delivery; Transfersomes

Indexed keywords

ANDROSTANOLONE; CHOLESTEROL; CHOLIC ACID; CIMETIDINE; COPPER ZINC SUPEROXIDE DISMUTASE; DEXAMETHASONE; DICLOFENAC; DIOLEOYL TRIMETHYL AMMONIUM PROPANE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; ECONAZOLE; ESTRADIOL; FLUOROURACIL; GAP JUNCTION PROTEIN; HYDROCORTISONE; INTERFERON; ISOTRETINOIN; LIDOCAINE; LIPOSOME; NIOSOME; PHOSPHATIDYLCHOLINE; PROGESTERONE; PROPRANOLOL; SORBITAN OLEATE; STEROID; TACROLIMUS; TETANUS TOXOID; TRANSFERSOME; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; DRUG; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ANTIBODY TITER; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG PENETRATION; DRUG TARGETING; HUMAN; IMMUNIZATION; IN VIVO STUDY; LIPID BILAYER; MACROMOLECULE; MOLECULAR WEIGHT; NONHUMAN; PSORIASIS; REVIEW; SKIN APPENDAGE; SKIN PENETRATION; STRATUM CORNEUM; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DELAYED RELEASE FORMULATION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; SKIN ABSORPTION;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION;

EID: 66949172541     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240802691059     Document Type: Review

References (103)

1. Barry BW. Dermatological formulations: percutaneous absorption. New York and Basel: Marcel Dekker; 1983
2. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101-114 (Pubitemid 32737532)
3. Williams AC. Transdermal and topical drug delivery: from theory to clinical practice. London: Pharmaceutical Press; 2003
4. Williams AC, Barry BW. Penetration enhancers. Adv Drug Del Rev 2004;56:603-618 (Pubitemid 38326936)
5. Megrab NA, Williams AC, Barry BW. Oestradiol permeation across human skin and silastic membranes: effects of propylene glycol and supersaturation. J Control Rel 1995;36:277-294
6. Leichtnam ML, Rolland H, Wüthrich P, Guy RH. Impact of antinucleants on transdermal delivery of testosterone from a spray. J Pharm Sci 2007;96:84-92 (Pubitemid 46087341)
7. Miller LL, Kolaskie CJ, Smith GA, Rivier J. Transdermal iontophoresis of gonadotropin releasing hormone and two analogues. J Pharm Sci 1990;79:490-493 (Pubitemid 20221392)
8. Prausnitz MR, Gimm JA, Guy RH, et al. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures. J Pharm Sci 1996;85:1363-1370
9. Kost J, Pliquett U, Mitragotri S, et al. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res 1996;13:633-638 (Pubitemid 26119070)
10. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliver Rev 2002;54:S77-98 (Pubitemid 35379956)
11. El Maghraby GM. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int J Pharm 2008;355:285-292
12. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for topical route of administration. 1. lotion dosage form. Life Sci 1980;26:1473-1477
13. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-232
14. Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel 1994;30:1-15 (Pubitemid 24173173)
15. El Maghraby GM, Williams AC, Barry BW. Can drug bearing liposomes penetrate intact skin? J Pharm Pharmacol 2006;58:415-429
16. Touitou E, Godin B, Weiss C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev Res 2000;50:406-415 (Pubitemid 30752157)
17. Touitou E, Dayan N, Bergelson L, et al. Ethosomes: novel vesicular carriers for enhanced delivery: characterisation and skin penetration properties. J Control Rel 2000;65:403-418 (Pubitemid 30122942)
18. El Maghbary GM, Williams AC, Barry BW. Liposomes and skin. From drug delivery to model membranes. Eur J Pharm Sci 2008;34:203-222
19. Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for topical route of administration: gel dosage form. J Pharm Pharmacol 1982;34:473-474 (Pubitemid 12082555)
20. Mezei M. Liposomes as a skin drug delivery system. In Breimer DD and Speiser P, editors, Topics in Pharmaceutical Sciences, Elsevier, Amsterdam, New York, Oxford, 1985. p. 345-358
21. Vermorken AJM, Hukkelhoven MWAC, Vermeesch-marksiag AMG, et al. The use of liposomes in topical application of steroids. J Pharm Pharmacol 1984;36:334-336 (Pubitemid 14101368)
22. Wohlrab W, Lasch J, Laub R, et al. Distribution of liposome-encapsulated ingredients in human skin ex vivo. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin 1992. p. 217-225
23. Fresta M, Puglisi G. Corticosteroid dermal delivery with skin-lipid liposomes. J Control Rel 1997;44:141-151 (Pubitemid 27039111)
24. Yu HY, Liao HM. Triamcinolone permeation from different liposome formulations through rat skin in vitro. Int J Pharm 1996;127:1-7 (Pubitemid 26069149)
25. Erdogan M, Wright JR, McAlister VC. Liposomal tacrolimus lotion as a novel topical agent for immune-mediated skin disorders: experimental studies in a murine model. Br J Dermatol 2002;146:964-967 (Pubitemid 34779475)
26. Gesztes A, Mezei M. Topical anesthesia of skin by liposome-encapsulated tetracaine. Aneth Analg 1988;67:1079-1081 (Pubitemid 18260751)
27. Foldvari M, Gesztes A, Mezei M. Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies. J Microencaps 1990;7(4):479-489
28. Foldvari M. In vitro cutaneous and percutaneous delivery and in vivo effecacy of tetracaine from liposomal and conventional vehicles. Pharm Res 1994;11(11):1593-1598
29. Hung OR, Comeau L, Riley MR, et al. Comparative topical anaesthesia of EMLA and liposome-encapsulated tetracaine. Can. J Anaesth 1997;44:707-711 (Pubitemid 27458673)
30. Fisher R, Hung O, Mezei M, Stewart R. Topical anaesthesia of intact skin: Liposome-encapsulated tetracaine vs EMLA. Br J Anaesth 1998;81:972-973 (Pubitemid 28561338)
31. Planas ME, Gonzalez P, Rodriguez L, et al. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Aneth Analg 1992;75:615-621
32. El Maghraby GM, Williams AC, Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 2001;53:1069-1077 (Pubitemid 32754937)
33. Cevc G, Blume G, Schätzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Rel 1997;45:211-226 (Pubitemid 27062973)
34. Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 2008;360:156-163
35. Lauer AC, Ramachandran C, Leib LM, et al. Targeted delivery to pilosebaceous unit via liposomes. Advanced Drug Del Rev 1996;18:311-324 (Pubitemid 26062291)
36. Lauer AC. Percutaneous drug delivery to the hair follicle. Third edition. In: Bronaugh RL, Maibach HI, editors, Percutaneous Absorption Drugs-Cosmetics-Mechanisms-Methodology, Marcel Dekker, Inc., New York. Basel, 1999. p. 427-449
37. Lieb LM, Ramachandran C, Egbaria K, Weiner N. Liposomally encapsulated active ingredients penetrate through the hair follicle. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin, 1992. p. 200-205
38. Lieb LM, Ramachandran C, Egbaria K, Weiner N. Topical delivery enhancement with multilamellar liposomes into pliosebaceous units: I. In vitro evaluation using fluorescent techniques with hamster ear model. J Invest Dermatol 1992;99(1):108-113
39. Lieb LM, Flynn G, Weiner N. Follicular (pilosebaceous unit) deposition and pharmacological behavior of cimetidine as a function of formulation. Pharm Res 1994;11(10):1419-1423
40. Touitou E, Schaffer FL, Dayan N, et al. Modulation of caffeine delivery by carrier design: liposomes versus permeation enhancers. Int J Pharm 1994;103:131-136 (Pubitemid 24037044)
41. Tschan T, Steffen H, Supersaxo A. Sebaceous-gland deposition of isotretinoin after topical application: an in vitro study using human facial skin. Skin Pharmacol 1997;10:126-134 (Pubitemid 27373369)
42. Skalko N, Cajkovac M, Jalsenjak I. Liposomes with clindamycin hydrochloride in therapy of acne vulgaris. Int J Pharm 1992;85:97-101
43. Meybeck A. Comedolytic activity of liposomal antiacne drug in an experimental model. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin, 1992. p. 235-241
44. Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes. 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323:1-10
45. Ganesan MG, Weiner ND, Flynn GL, Ho NFH. Influence of liposomal drug entrapment on percutaneous absorption. Int J Pharm 1984;20:139-154 (Pubitemid 14091715)
46. Bonina FB, Montenegro L, Scrofani N, et al. Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate. J Control Rel 1995;34:53-63
47. Fresta M, Puglisi G. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactivity labelled vesicles. J Drug Target 1996;4:95-101
48. Simoes SI, Martins MBF, Cruz MEM, Cevc G. Anti-inflammatory effects of Cu, Zn-superoxide dismutase in liposomes, Transfersomes or micelles, in the acute murine ear edema model. In: Brain KR, Walters KA, editors, Perspectives in Percutaneous Penetration, sixth International Conference, Vol.6a, STS Publishing, Cardiff, 1998. p. 50
49. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies. J Pharm Pharmacol 1999;51:1123-1134 (Pubitemid 29520458)
50. El Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 2000;196:63-74 (Pubitemid 30089515)
51. El Maghraby GM, Williams AC, Barry BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 2004;276:143-161 (Pubitemid 38542995)
52. Cevc G. Rational for the production and dermal application of lipid vesicles. In: Falco OB, Korting HC, Maibach HI, editors, Liposome Dermatics, Springer-Verlag, Berlin, 1992. p. 82-90
53. Cevc G. Material transport across the permeability barriers by means of lipid vesicles. In: Lipowsky R, Sackmann E, editors, Handbook of Biological Physics, Vol.1, Elsevier Science B.V., North Holland, Amsterdam, 1995. p. 465-490
54. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Car Sys 1996;13(3&4):257-388 (Pubitemid 27024259)
55. Honeywell-Nguyen PL, Arenja S, Bouwstra JA. Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm Res 2003;20(10):1619-1625 (Pubitemid 37268278)
56. Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 2004;123(5):902-910 (Pubitemid 39391936)
57. Weiner N, Williams N, Birch G, et al. Topical delivery of liposomally encapsulated interferon evaluated in cutaneous herpes guinea pig model. Antimicrob Agents Chemother 1989;33(8):1217-1221 (Pubitemid 19191960)
58. Egbaria K, Ramachandran C, Kittayanond D, Weiner N. Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies. Antimicrob Agents Chemother 1990;34(1):107-110 (Pubitemid 20019973)
59. Egbaria K, Ramachandran C, Weiner N. Topical delivery of cyclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin. Skin Pharmacol 1990;3:21-28 (Pubitemid 20242148)
60. Du Plessis J, Egbaria K, Ramachandran C, Weiner ND. Topical delivery of liposomally encapsulated gamma-interferon. Antiviral Res 1992;18:259-265
61. Artman C, Roding J, Ghyczy M, Prazel HG. Liposomes from soya phospholipids as percutaneous drug carriers: Qualitative in vivo investigations with antibody-loaded liposomes. Arzneium Forsch Drug Res 1990;40(II):1363-1365
62. Artman C, Roding J, Ghyczy M, Prazel HG. Liposomes from soya phospholipids as percutaneous drug carriers: Quantitative in vivo investigations with radioactivity labelled liposomes. Arzneium. Forsch Drug Res 1990;40(II):1365-1368
63. Short SM, Paasch BD, Turner JH, et al. Percutaneous absorption of biologically-active interferon-gamma in a human skin graft-nude mouse model. Pharm Res 1996;13(7):1020-1027 (Pubitemid 26259001)
64. Cevc G, Schätzlein A, Gebauer D, Blume G. Ultra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, transfersomes. In: Brain KR, James VA, Walters KA, editors, Prediction of Percutaneous Penetration, Third International Conference, 14-16 April, Vol.3b, STS Publishing, Cardiff, 1993. p. 226-236
65. Cevc G, Schätzlein A, Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Rel 1995;36:3-16
66. Cevc G, Gebauer D, Stieber J, et al. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1998;1368:201-215 (Pubitemid 28031874)
67. Song YK, Kim CK. Topical delivery of low-molecular-weight heparinwith surface-charged flexible liposomes. Biomaterials 2006;27:271-280 (Pubitemid 41278529)
68. Paul A, Cevc G, Bachhawat BK. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, Transfersomes. Vaccine 1998;16:188-195 (Pubitemid 27520997)
69. Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 2005;293:73-82 (Pubitemid 40381082)
70. Mishra V, Mahor S, Rawat A, et al. Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 2006;24:5559-5570 (Pubitemid 43867105)
71. Vyas SP, Singh RP, Jain S, et al. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 2005;296:80-86 (Pubitemid 40693375)
72. Mahor S, Rawat A, Dubey PK, et al. Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm 2007;340:13-19 (Pubitemid 47043347)
73. Mishra D, Dubey V, Asthana A, et al. Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine 2006;24:4847-4855 (Pubitemid 43776800)
74. Mishra D, Mishra PK, Dubey V, et al. Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes. Vaccine 2007;25(39-40):6939-6944 (Pubitemid 47391101)
75. Mishra D, Mishra PK, Dubey V, et al. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. Eur J Pharm Sci 2008;33:424-433
76. Kato A, Ishibashi Y, Miyake Y. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 1987;39:399-400 (Pubitemid 17119501)
77. Hofland HEJ, Bouwstra JA, Bodde HE, et al. Interaction between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies. Br J Dermatol 1995;132:853-866
78. Korting HC, Stolz W, Schmid MH, Maierhofer G. Interaction of liposomes with human epidermis reconstructed in vitro. Britsh J Dermatol 1995;132:571-579
79. Zellmer S, Pfeil W, Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim Biophys Acta 1995;1237:176-182
80. Kirjavainen M, Urtti A, Jaaskelainen I, et al. Interaction of liposomes with human skin in vitro- the influence of lipid composition and structure. Biochim Biophys Acta 1996;1304:179-189 (Pubitemid 26426990)
81. Kirjavainen M, Urtti A, Koskela RV, et al. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999;7:279-286 (Pubitemid 29080739)
82. Yokomizo Y, Sagitani H. Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of the guinea pig, in vitro. J Control Rel 1996;38:267-274 (Pubitemid 26098646)
83. Yokomizo Y, Sagitani H. Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of the guinea pig, in vitro. 2. The effects of hydrophobic group in the phosphlipids and a comparison with general enhancers. J Control Rel 1996;42:37-46
84. Jacobs M, Martin GP, Marriott C. Effects of phosphatidylcholine on the topical bioavailability of corticosteroids assessed by the human skin blanching assay. J Pharm Pharmacol 1988;40:829-833 (Pubitemid 19025326)
85. Du Plessis J, Weiner N, Muller DG. The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drug in vitro. Int J Pharm 1994;103:R1-5 (Pubitemid 24037039)
86. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm 2000;204:159-169 (Pubitemid 30782338)
87. Kim MK, Chung SJ, Lee MH, et al. Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J Control Rel 1997;46:243-251 (Pubitemid 27132848)
88. Kirjavainen M, Monkkonen J, Saukkosaari M, et al. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Rel 1999;58:207-214 (Pubitemid 29112891)
89. Keith AD, Snipes W. Phospholipids as moisturizing agents. In: Frost P, Horovitz S, editors, Principles of Cosmetics for the Dermatologist, The C.V. Mosby Company: St. Louis, 1982. p. 59-69
90. Korting HC, Zeinicke H, Schafer KM, Falco OB. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur J Clin Pharmacol 1990;39:349-351 (Pubitemid 20362344)
91. Lasch J, Laub R, Wohlrab W. How deep do intact liposomes penetrate into human skin? J Control Rel 1991;18:55-58
92. Du Plessis J, Ramachandran C, Weiner N, Muller DG. The influence of particle size of liposomes on the disposition of drug into skin. Int J Pharm 1994;103:277-282 (Pubitemid 24073689)
93. Masini V, Bonte F, Meybeck A, Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin liposomes or gel. J Pharm Sci 1993;82(1):17-21 (Pubitemid 23148842)
94. Valenta C, Janisch M. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm 2003;258:133-139 (Pubitemid 36712877)
95. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substance into skin. Int J Pharm 2003;258:141-151 (Pubitemid 36712878)
96. Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319-327 (Pubitemid 34718033)
97. Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate skin and other semi-permeable membrane barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement. Biochim Biophys Acta 2002;1564:21-30
98. Cevc G, Gebauer D. Hydration-driven transport of deformable lipid vesicles through fine pores and skin barrier. Biophys J 2003;84:1010-1024 (Pubitemid 36133426)
99. Honeywell-Nguyen PL, Wouter Groenink HW, de Graaff AM, Bouwstra JA. The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Rel 2003;90(2):243-255
100. Schramlova J, Blazek K, Bartackova M, et al. Electron microscopic demonstration of the penetration of liposomes through skin. Folia Biol 1997;43(4):165-169 (Pubitemid 27309597)
101. El Maghraby GM, Williams AC, Barry BW. Skin hydration and possible shunt route penetration in controlled skin delivery of estradiol from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 2001;53:1311-1322 (Pubitemid 32982247)
102. Han I, Kim M, Kim J. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exp Dermatol 2004;13(2):86-92 (Pubitemid 38247866)
103. Cevc G, Blume G, Schätzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Advanced Drug Del Rev 1996;18:349-378 (Pubitemid 26063309)